A Study to Determine the Effect of KP-001 on Metformin and Midazolam Pharmacokinetics and the Effect of Clarithromycin on KP-001 Pharmacokinetics in Healthy Adult Participants
Clinical trial NCT06227832 · COMPLETED
Trial details
- NCT number
- NCT06227832
- Sponsor
- Kaken Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-15
- Primary completion
- 2024-03-15
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.